31Jul
Department of Justice fines pharmaceutical company
Compliance Today (August 2020) - On May 7, the Department of Justice’s Antitrust Division announced a deferred prosecution agreement, in which Apotex Corp. agreed to pay a $24.1 million criminal penalty for price-fixing. The Florida-based company conspired with competitors to increase and maintain the price of pravastatin, a commonly prescribed cholesterol medication that lowers the risk of heart disease and stroke....
By:
Health Care Compliance Association (HCCA)
Related
On 21 June 2020, the UK Government announced that it is introducing emergency legislation that will ...
Read More >
On September 11, 2020, OFCCP released its Corporate Scheduling Announcement List (CSAL). The list id...
Read More >
Abry Partners has acquired HealthEZ, according to a news release. HealthEZ, founded in 1982 and bas...
Read More >
In this episode of Trekking Through Compliance, we consider the episode The Savage Curtain which air...
Read More >
As 2019 comes to a close, here is a look ahead to some of the legislation going into effect on Janua...
Read More >
The act amending the Act on the National Housing Resources was signed by the President on 2 July 201...
Read More >